These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36156598)

  • 1. A comparison of neoadjuvant therapies for gastroesophageal and gastric cancer on tumour resection rate: A network meta-analysis.
    Herng SC; Htet NH; Naing C
    PLoS One; 2022; 17(9):e0275186. PubMed ID: 36156598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis.
    Wang T; Li C; Li X; Zhai J; Wang S; Shen L
    Eur J Med Res; 2022 Nov; 27(1):239. PubMed ID: 36352476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y
    PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of the outcomes following neoadjuvant therapy in upfront resectable gastric cancers compared to surgery alone in phase III randomised controlled trials.
    Lim Khai Shin A; Ho Si Ying A; Neo Hui Wen S; Yeo SC; Tay KV
    J Gastrointest Surg; 2023 Jun; 27(6):1261-1276. PubMed ID: 36882627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.
    Zhu Y; Chen J; Sun X; Lou Y; Fang M; Zhou F; Zhang L; Xin Y
    Front Oncol; 2023; 13():1177557. PubMed ID: 37228495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.
    Xiong BH; Cheng Y; Ma L; Zhang CQ
    Cancer Invest; 2014 Jul; 32(6):272-84. PubMed ID: 24800782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neoadjuvant regimens for resectable gastroesophageal junction cancer: a systematic review of randomized clinical trials across three decades.
    Nishikawa G; Banik P; Thawani R; Kardosh A; Wood SG; Nabavizadeh N; Chen EY
    J Gastrointest Oncol; 2022 Jun; 13(3):1454-1466. PubMed ID: 35837173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005047. PubMed ID: 17943834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review.
    Wang J; Tong T; Zhang G; Jin C; Guo H; Liu X; Zhang Z; Li J; Zhao Y
    Front Immunol; 2024; 15():1339757. PubMed ID: 38352873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.
    Liao Y; Yang ZL; Peng JS; Xiang J; Wang JP
    J Gastroenterol Hepatol; 2013 May; 28(5):777-82. PubMed ID: 23425049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefits from neoadjuvant treatment in gastric cancer: a systematic review and meta-analysis.
    Hu J; Yang Y; Ma Y; Ning Y; Chen G; Liu Y
    Syst Rev; 2022 Jul; 11(1):136. PubMed ID: 35788246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
    Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005047. PubMed ID: 17443566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.